BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 27212584)

  • 1. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
    Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
    Tamura SI; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
    Eur J Immunol; 1992 Feb; 22(2):477-81. PubMed ID: 1537382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.
    Asanuma H; Zamri NB; Sekine S; Fukuyama Y; Tokuhara D; Gilbert RS; Fukuiwa T; Fujihashi K; Sata T; Tashiro M; Fujihashi K
    Vaccine; 2012 Jan; 30(4):803-12. PubMed ID: 22100889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
    Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF
    Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses.
    Kimoto T; Mizuno D; Takei T; Kunimi T; Ono S; Sakai S; Kido H
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1218-26. PubMed ID: 23710832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.
    Kammoun H; Roux X; Raze D; Debrie AS; De Filette M; Ysenbaert T; Mielcarek N; Saelens X; Fiers W; Locht C
    PLoS One; 2013; 8(3):e59198. PubMed ID: 23555631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers.
    Bean R; Giurgea LT; Han A; Czajkowski L; Cervantes-Medina A; Gouzoulis M; Mateja A; Hunsberger S; Reed S; Athota R; Baus HA; Kash JC; Park J; Taubenberger JK; Memoli MJ
    mBio; 2024 Feb; 15(2):e0237223. PubMed ID: 38193710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
    Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
    J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice.
    Choi A; Bouzya B; Cortés Franco KD; Stadlbauer D; Rajabhathor A; Rouxel RN; Mainil R; Van der Wielen M; Palese P; García-Sastre A; Innis BL; Krammer F; Schotsaert M; Mallett CP; Nachbagauer R
    Immunohorizons; 2019 Apr; 3(4):133-148. PubMed ID: 31032479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
    Couch RB; Atmar RL; Cate TR; Quarles JM; Keitel WA; Arden NH; Wells J; Niño D; Wyde PR
    Vaccine; 2009 Aug; 27(39):5344-8. PubMed ID: 19607949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit.
    Gizurarson S; Tamura S; Aizawa C; Kurata T
    Vaccine; 1992; 10(2):101-6. PubMed ID: 1539462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant-free parenterally injectable vaccine platform that harnesses previously induced IgG as an antigen delivery carrier.
    Kawai A; Hirata H; Tokunoh N; Ono C; Matsuura Y; Hirai T; Yoshioka Y
    Biochem Biophys Res Commun; 2024 Jun; 711():149919. PubMed ID: 38608435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine.
    Spencer MJ; Cherry JD; Powell KR; Sumaya CV; Garakian AJ
    J Infect Dis; 1975 Oct; 132(4):415-20. PubMed ID: 1102614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.
    Ben Ahmeida ET; Jennings R; Erturk M; Potter CW
    Arch Virol; 1992; 125(1-4):71-86. PubMed ID: 1642561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
    Tong X; Deng Y; Cizmeci D; Fontana L; Carlock MA; Hanley HB; McNamara RP; Lingwood D; Ross TM; Alter G
    J Immunol; 2024 Jan; 212(1):24-34. PubMed ID: 37975667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic influenza haemagglutinin-specific antibody responses following aerosol and subcutaneous administration of inactivated split influenza vaccine.
    Oh Y; Ohta K; Kuno-Sakai H; Kim R; Kimura M
    Vaccine; 1992; 10(8):506-11. PubMed ID: 1621413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen.
    Falkeborn T; Hinkula J; Olliver M; Lindberg A; Maltais AK
    Virol J; 2017 Mar; 14(1):44. PubMed ID: 28253901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity,, immunogenicity, and protection efficacy.
    Rytel MW; Jackson LJ; Ferstenfeld JE; Rosenkranz MA
    J Infect Dis; 1975 Dec; 132(6):652-9. PubMed ID: 1202110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.